149 related articles for article (PubMed ID: 12623122)
1. Corticotropin-releasing hormone (CRH) and immunotolerance of the fetus.
Makrigiannakis A; Zoumakis E; Kalantaridou S; Mitsiades N; Margioris A; Chrousos GP; Gravanis A
Biochem Pharmacol; 2003 Mar; 65(6):917-21. PubMed ID: 12623122
[TBL] [Abstract][Full Text] [Related]
2. Participation of maternal and fetal CRH in early phases of human implantation: the role of antalarmin.
Makrigiannakis A; Zoumakis E; Kalantaridou S; Chrousos G; Gravanis A
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Mar; 4(1):75-8. PubMed ID: 15032629
[TBL] [Abstract][Full Text] [Related]
3. The role of corticotropin-releasing hormone in blastocyst implantation and early fetal immunotolerance.
Kalantaridou SN; Zoumakis E; Makrigiannakis A; Godoy H; Chrousos GP
Horm Metab Res; 2007 Jun; 39(6):474-7. PubMed ID: 17578767
[TBL] [Abstract][Full Text] [Related]
4. Reproductive corticotropin releasing hormone, implantation, and fetal immunotolerance.
Kalantaridou SN; Zoumakis E; Weil S; Lavasidis LG; Chrousos GP; Makrigiannakis A
Crit Rev Clin Lab Sci; 2007; 44(5-6):461-81. PubMed ID: 17943493
[TBL] [Abstract][Full Text] [Related]
5. Endometrial and placental CRH as regulators of human embryo implantation.
Makrigiannakis A; Zoumakis E; Kalantaridou S; Chrousos G
J Reprod Immunol; 2004 Jun; 62(1-2):53-9. PubMed ID: 15288181
[TBL] [Abstract][Full Text] [Related]
6. Immune function in pregnancy: the role of corticotropin-releasing hormone.
Makrigiannakis A; Gravanis A
Expert Rev Endocrinol Metab; 2008 May; 3(3):315-325. PubMed ID: 30754199
[TBL] [Abstract][Full Text] [Related]
7. Uterine and embryonic trophoblast CRH promotes implantation and maintenance of early pregnancy.
Makrigiannakis A; Zoumakis E; Kalantaridou S; Chrousos G; Gravanis A
Ann N Y Acad Sci; 2003 Nov; 997():85-92. PubMed ID: 14644813
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance.
Makrigiannakis A; Zoumakis E; Kalantaridou S; Coutifaris C; Margioris AN; Coukos G; Rice KC; Gravanis A; Chrousos GP
Nat Immunol; 2001 Nov; 2(11):1018-24. PubMed ID: 11590404
[TBL] [Abstract][Full Text] [Related]
9. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.
Mastorakos G; Ilias I
Ann N Y Acad Sci; 2003 Nov; 997():136-49. PubMed ID: 14644820
[TBL] [Abstract][Full Text] [Related]
10. Peripheral corticotropin-releasing hormone is produced in the immune and reproductive systems: actions, potential roles and clinical implications.
Kalantaridou S; Makrigiannakis A; Zoumakis E; Chrousos GP
Front Biosci; 2007 Jan; 12():572-80. PubMed ID: 17127318
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of peripheral corticotropin-releasing hormone (CRH).
Ilias I; Mastorakos G
J Endocrinol Invest; 2003 Apr; 26(4):364-71. PubMed ID: 12841546
[TBL] [Abstract][Full Text] [Related]
12. Endometrial CRH and implantation: from bench to bedside.
Makrigiannakis A; Vrekoussis T; Zoumakis E; Hatzidakis V; Vlachou E; Salakos N; Kalantaridou SN
Hormones (Athens); 2018 Sep; 17(3):293-297. PubMed ID: 29916119
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis.
Petsas G; Jeschke U; Richter DU; Minas V; Hammer A; Kalantaridou S; Toth B; Tsatsanis C; Friese K; Makrigiannakis A
Mol Hum Reprod; 2012 Nov; 18(11):535-45. PubMed ID: 22763913
[TBL] [Abstract][Full Text] [Related]
14. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
Kauma SW; Huff TF; Hayes N; Nilkaeo A
J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
[TBL] [Abstract][Full Text] [Related]
15. Presence of immunoreactive corticotropin-releasing hormone in human endometrium.
Mastorakos G; Scopa CD; Kao LC; Vryonidou A; Friedman TC; Kattis D; Phenekos C; Rabin D; Chrousos GP
J Clin Endocrinol Metab; 1996 Mar; 81(3):1046-50. PubMed ID: 8772574
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin releasing hormone (CRH) in normal and pregnant uterus: physiological implications.
Zoumakis E; Makrigiannakis A; Margioris A; Stournaras C; Gravanis A
Front Biosci; 1996 Jan; 1():e1-8. PubMed ID: 9159239
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system.
Kayisli UA; Selam B; Guzeloglu-Kayisli O; Demir R; Arici A
J Immunol; 2003 Sep; 171(5):2305-13. PubMed ID: 12928375
[TBL] [Abstract][Full Text] [Related]
18. Reproductive functions of corticotropin-releasing hormone. Research and potential clinical utility of antalarmins (CRH receptor type 1 antagonists).
Kalantaridou SN; Makrigiannakis A; Zoumakis E; Chrousos GP
Am J Reprod Immunol; 2004 Apr; 51(4):269-74. PubMed ID: 15212679
[TBL] [Abstract][Full Text] [Related]
19. Endometrial corticotropin-releasing hormone: expression, regulation, and potential physiological implications.
Makrigiannakis A; Psychoyos A; Zoumakis E; Margioris AN; Stournaras C; Gravanis A
Ann N Y Acad Sci; 1997 Jun; 816():116-28. PubMed ID: 9238261
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
